Blood pressure

UM, Baptist clinical trial exploring ways to tackle severe hypertension



Both UM and Baptist are still enrolling new patients in the trial. To learn more, contact the researchers at UM at 305-243-9200 or at Baptist at 786-596-5990. You can also visit the website for the Medtronic Symplicity trial at

Marie Joseph just might be the ideal candidate for an experimental treatment for drug-resistant hypertension.

For the past several years, she has been on five medications to treat her hypertension. But they haven’t had much of an impact. Joseph’s systolic blood pressure — the top number — is sometimes over 200, and has been as high as 228.

“My blood pressure makes me very stressed,” said Joseph, who is 51. “Whenever my blood pressure is high, my heart starts beating fast, like if I was feeling chest pains. A week ago I had to go to the hospital because my heart rate went up to 160 beats per minute. That’s very dangerous.”

Recently, both her cardiologist and nephrologist (a kidney specialist) at the University of Miami suggested that Joseph consider participating in a clinical trial for a new treatment for severe hypertension. In South Florida, both UM and the Baptist Cardiac & Vascular Institute are site locations for the Symplicity HTN-3 clinical trial. Medtronic is the medical company behind the national study.

Experts have long known that the kidney is a key player in blood pressure regulation. The kidneys are part of what’s called the sympathetic nervous system, which controls the “fight or flight” response.

But in patients with hypertension, the nerves around the kidneys are hyperactive and actually elevate blood pressure.

In the Symplicity trial, doctors attempt to lower blood pressure by using a radio frequency to disrupt or “zap” these hyperactive renal nerves. They do this by inserting a catheter into the patient’s groin and placing it into the artery that leads to the kidney. The catheter is then switched out for the experimental medical device, which emits radio-frequency energy through the artery walls to disrupt the nerves.

This process, which is completed in a single procedure, is called renal denervation.

“The idea is to go through the renal artery and injure those nerves without injuring other types of tissues,” said Dr. Barry T. Katzen, who directs the Baptist Cardiac & Vascular Institute.

The technology has already gone through trials outside the United States and has been shown to reduce high blood pressure in extreme cases of hypertension, although it is not a substitute for drugs. However, patients who have gone through the process have been able to lessen the number of medications they take.

“The studies in Europe have shown a decrease in blood pressure by as much as 30 millimeters of mercury over several months in patients that have had this technique done,” said Dr. Eduardo de Marchena, a professor at the UM Miller School of Medicine who is the primary investigator at UM for the Symplicity trial. “That means a patient with a systolic blood pressure of 180 could drop to 150.”

About 70 million people in the United States have hypertension, and most of those are able to control their blood pressure with one or more medications. But for about 5 to 10 percent of patients, the drugs don’t seem to have an impact.

“This [trial] has the potential to be transformational for that subgroup,” said Katzen. “If you reduce the systolic blood pressure you can significantly reduce the risk of heart attack and stroke. This is a potentially very important advance because those patients, right now, are offered no hope.”

To comply with FDA standards, the clinical trial is rigorous. Most patients don’t qualify to be candidates. De Marchena said he’s screened more than 80 patients at the UM site but only a handful met the qualifications to participate. Similarly at Baptist, only about one of every 25 patients screened for the trial have been enrolled, said Dr. Alex Powell, the site’s principal investigator.

To participate, patients must be between 18 and 80, and have a systolic blood pressure reading that’s usually more than 160. They must also be taking three or more prescription medications for high blood pressure, including one diuretic, and can’t have a history of major kidney problems.

“The main reason people do not qualify for the trial is the requirement of being on three medications at the maximum dosing levels,” Powell said. “Also, I’ve had several patients who could not take a diuretic. Getting people enrolled is very difficult.”

The study is controlled, which means that some of the enrolled patients will be given a placebo instead of the device, in order to serve as a control group. However, after six months, patients in the control group will be offered the procedure for free if they are interested.

After talking about the trial with her primary care doctor and reading information online, Joseph began the initial candidate tests for the trial. She is currently monitoring her blood pressure every day as part of the screening process.

“I’m really interested in it because I feel like I’m going to get somewhere, finally,” she said. “I would be more than pleased to participate to see if I can get my blood pressure resolved.”

Read more Health stories from the Miami Herald

Gena Barr, outreach coordinator for the University of Miami Health System's Division of Adolescent Medicine, demonstrates how she conducts a urine sample test that determines the presence of STDs. Barr, 39, has been working at the UM clinic since 2004. “I just wanted to help people in the community," she said, adding added that the clinic, located at the Coordinated Victims Assistance Center which primarily serves domestic abuse victims, gave her the opportunity.


    STDs are on the rise in Miami-Dade

    Cases of chlamydia and syphilis have almost doubled in the last seven years, causing concern and speculation about the increase.

  • Cancer

    Fasting can improve chemo effects

    The history of cancer treatment includes a long list of quack diets claiming patients can eat their way back to good health, but one approach, which involves eating less and minimizing carbohydrates, appears to produce genuine benefits.

  • chew on this

    Chew on This: Spices make food flavorful, and more healthy

    Science has once again validated observation and common sense. This time it is herbs and spices going through scientific review.

Miami Herald

Join the

The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

The Miami Herald uses Facebook's commenting system. You need to log in with a Facebook account in order to comment. If you have questions about commenting with your Facebook account, click here.

Have a news tip? You can send it anonymously. Click here to send us your tip - or - consider joining the Public Insight Network and become a source for The Miami Herald and el Nuevo Herald.

Hide Comments

This affects comments on all stories.

Cancel OK

  • Marketplace

Today's Circulars

  • Quick Job Search

Enter Keyword(s) Enter City Select a State Select a Category